PD-1 blockade in tumors with mismatch repair deficiency.
Dung T. Le(Sidney Kimmel Comprehensive Cancer Center), Jennifer N. Uram(Sidney Kimmel Comprehensive Cancer Center), Hao Wang(Sidney Kimmel Comprehensive Cancer Center), Bjarne R. Bartlett(Sidney Kimmel Comprehensive Cancer Center), Holly Kemberling(Sidney Kimmel Comprehensive Cancer Center), Aleksandra Eyring(Sidney Kimmel Comprehensive Cancer Center), Andrew D. Skora(Sidney Kimmel Comprehensive Cancer Center), Nilofer S. Azad(Sidney Kimmel Comprehensive Cancer Center), Daniel A. Laheru(Sidney Kimmel Comprehensive Cancer Center), Ross C. Donehower(Johns Hopkins University), Brandon Luber(Sidney Kimmel Comprehensive Cancer Center), Todd S. Crocenzi(Providence Portland Medical Center), George A. Fisher(Stanford University), Steve M Duffy(Bon Secours Health System), James J. Lee(University of Pittsburgh), Minori Koshiji(Merck & Co., Inc., Rahway, NJ, USA (United States)), James R. Eshleman(Johns Hopkins University), Robert A. Anders(Johns Hopkins University), Bert Vogelstein(Johns Hopkins University), Luis A. Díaz(Sidney Kimmel Comprehensive Cancer Center)
Cited by 553
Abstract
LBA100 The full, final text of this abstract will be available at abstracts.asco.org at 2:00 PM (EDT) on Friday, May 29, 2015, and in the Annual Meeting Proceedings online supplement to the June 20, 2015, issue of the Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.
Related Papers
No related papers found
Powered by citation graph analysis